NOTICE OF UPGRADE

Our websites will be unavailable between the hours of AEST 4AM September 17, 2022 and AEST 11PM on date September 18, 2022

InvestoGain Australia
 

SEARCH LISTED COMPANY


Any AUS or NZ company

Browse Australian listed companies

0-9A B C D E F G H I J K L M N O P Q R S T U V W XY Z

Browse current Australian managed funds

0-9A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

SEARCH PRIVATE COMPANY


SEARCH FUNDS

Find any Australian or New Zealand company or fund (dead or alive) by using SEARCH above or go directly to the site:

ELIXINOL GLOBAL LIMITED (EXL)

Click here for free access to this company's:
ASX, Legal & CGT Status

Former (or subsequent) names

Shareholder links

Our website ranking of EXL: rating 4
(4 out of 5)
COMPANY WEBSITE:

 

REGISTRY:

Automic Group
Level 5, 191 ST GEORGES TERRACE PERTH WA 6000
Tel : +61 (2) 8072 1400 or 1300 288 664 (within Australia)
RegistryWebsite RegistryEmail

Company details

ISIN: AU000000EXL4
Address: Level 12, 680 George Street, Sydney NSW 2000
Tel:  +61 2 9161 4275

Date first listed: 08/01/2018
Company Secretary: Josephine Lorenz, Sarah Prince
Sector: Household & Personal Products 
Activities: Manufacture and distribution of industrial hemp products and early stage medical cannabis business focusing on the importation, cultivation, manufacture and distribution of CBD and THC products

News & Events

Expand this box to read and print

name changed to Elixinol Wellness Limited

19/05/2021

The suspension of trading in the securities of Elixinol Global Limited will be lifted immediately following the release by EXL of an announcement regarding a binding agreement to acquire CannaCare Health GmbH.

15/03/2021

Elixinol signs binding agreement to acquire CannaCare Health GmbH, owner of CANOBO, one of Germany's leading CBD brands with #1 share in Germany's drugstore channel. Expected to fast-track revenue and path to profitability growth for the Group. Proposed acquisition is highly synergistic, enabling consolidation of European supply chain, ability to leverage existing cost base and capabilities and expand the combined product portfolio into new geographies and categories. The combination of CannaCare with Elixinol's UK business is expected to create a pan-European business of scale, well positioned to capitalise on a burgeoning European CBD market. Follows recent down-scheduling of CBD in Europe and aligns with Elixinol's vision of becoming "a global, hemp derived health and wellness consumer products business". Elixinol Board to be strengthened with the addition of Frank Otto, CannaCare's major shareholder and media entrepreneur. Completion is subject to satisfaction of customary conditions precedent, approvals from the ASX and approval by Elixinol's shareholders, expected to be sought at the upcoming Annual General Meeting, anticipated to be held in mid-May 2021. Investor briefing to be held on Tuesday 16 March 2021 at 11:00am, AEDT.

15/03/2021

The securities of Elixinol Global Limited will be suspended from quotation immediately under Listing Rule 17.2, at the request of EXL, pending the release of an announcement regarding a potential transaction.

08/03/2021

listed entity carried for record purposes only

08/01/2018

 

Click here for free access to this company's:
ASX, Legal & CGT Status

Your comments

Please read our Terms before viewing comments.

 

Company Updates

Post your comments here

Please read our Terms before posting comments.
OMISSIONS
    You can post a comment here about this company

    Please click in the "I'm not a robot" box and enter the word/figures you see in the image that then appears.

    loading Posting your comments. Please wait...

     


     

    Click here for free access to this company's:
    ASX, Legal & CGT Status

    Directors' on-market share transactions (last 5)

    rss feeds

    Purchases Sales

    DATEDIRECTORNUMBERPRICEAMOUNT
    21/09/2023Pauline Gately-3,349,581$0.007$23,447
    18/10/2021Helen Wiseman112,000$0.091$10,192
    29/09/2020Helen Wiseman79,896$0.155$12,384
    28/09/2020Oliver Horn90,000$0.150$13,500
    16/09/2020Paul Benhaim-8,100,000$0.148$1,200,000

    Click here for the last 20 transactions all companies

    Directors & Executives (current)

    NAMETITLEDATE OF APPT
    David FenlonChairman28/03/2022
    Ron DufficyManaging Director, CEO08/01/2018
    Josephine LorenzCFO08/04/2022
    Pauline GatelyNon Exec Director17/08/2023

    Date of first appointment, title may have changed.

    Directors & Executives (former)

    NAMETITLEDATE OF APPOINTMENTDATE OF RESIGNATION
    Helen WisemanChairman21/04/202030/09/2023
    Paul BenhaimNon Exec Director06/09/201706/04/2023
    Oliver HornNon Exec Director21/04/202006/04/2023
    Stratos KarousosExecutive Director, CEO04/09/201721/04/2020
    Andrew DuffNon Exec Chairman, Independent Director27/11/201706/04/2020
    Greg ElleryNon Exec Director12/04/201906/04/2020
    Linda McLeodExecutive04/09/201720/07/2019

    Date of first appointment, title may have changed.